Home
About us
News
Products
中 /
En
News
NEWS CENTER
Your present position:
Home
>
Laws & Regulations
Company News
Laws & Regulations
Registration
07/31
2020
Procedures & Technical Requirements for Drug Registration Inspection (Version 2020)
07/01
2020
Charging Rates for Drug Registration
Charging Rates for Drug Registration
04/08
2020
Baidu promotion materials
Baidu promotion materials
03/23
2020
Policy updates (as at 16th July 2019) (56th Announcement in 2019)
Policy updates (as at 16th July 2019) (56th Announcement in 2019)
03/23
2020
Ports that are approved by the State Council of China for importing pharmaceutical materials
The 22 ports that are approved by the state council of China to import pharmaceutical materials into China (as at July 2019)
03/18
2020
VAT Discounts for the First Batch of Orphan Drugs Officially Landed
VAT Discounts for the First Batch of Orphan Drugs Officially Landed
03/18
2020
NMPA Issued the Announcement on the Cessation of Production, Sale and Use of Furazolidone-Containing
NMPA Issued the Announcement on the Cessation of Production, Sale and Use of Furazolidone-Containing Compound Preparations
03/18
2020
NMPA Issued the Announcement on Revising the Package Inserts of Cefoperazone-Containing Drugs
NMPA Issued the Announcement on Revising the Package Inserts of Cefoperazone-Containing Drugs
03/18
2020
NMPA Issued the Announcement on the Selection and Determination Procedures for Reference Formulation
NMPA Issued the Announcement on the Selection and Determination Procedures for Reference Formulations of Chemical Generic Drugs
03/18
2020
NMPA Issued the Guidelines for the Collection and Reporting of Adverse Drug Reactions in Individual
NMPA Issued the Guidelines for the Collection and Reporting of Adverse Drug Reactions in Individual Cases
Jump to the first
page
determine